Proposal for a program to enhance renal transplantation opportunity for highly sensitized patients

Authors

  • Érika Fernandes Campos Immunogenetics Division, Pediatrics Department, Universidade Federal de São Paulo, São Paulo, SP, Brasil/Associação Fundo de Incentivo à Psicofarmacologia, São Paulo, SP, Brasil.
  • Ilias Ioannis Nikolaos Doxiadis Eurotransplant Reference Laboratory, Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.
  • Julia Temin Associação Fundo de Incentivo à Psicofarmacologia, São Paulo, SP, Brasil.
  • Andrea Plothow Associação Fundo de Incentivo à Psicofarmacologia, São Paulo, SP, Brasil.
  • Elaine Cristina Bellintani Associação Fundo de Incentivo à Psicofarmacologia, São Paulo, SP, Brasil.
  • Yuriko Miyamoto Associação Fundo de Incentivo à Psicofarmacologia, São Paulo, SP, Brasil.
  • Lidia Vieira Dantas Associação Fundo de Incentivo à Psicofarmacologia, São Paulo, SP, Brasil.
  • José Osmar Medina-Pestana Nephrology Division/Hospital do Rim e Hipertensão, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
  • Frans Claas Eurotransplant Reference Laboratory, Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.
  • Maria Gerbase-DeLima Immunogenetics Division, Pediatrics Department, Universidade Federal de São Paulo, São Paulo, SP, Brasil/Associação Fundo de Incentivo à Psicofarmacologia, São Paulo, SP, Brasil..

DOI:

https://doi.org/10.53855/bjt.v13i1.223

Keywords:

Antibodies, HLA, Kidney Transplantation, Histocompatibility

Abstract

Purpose: The accumulation of highly sensitized patients (HSP) on renal transplant waiting lists is a universal problem and finding donors for them represents a major challenge for organ distribution organizations. The purpose of this report is to describe a possible Brazilian version of the Eurotransplant Acceptable Mismatch program and the results of a study performed to test its efficiency. Method: The acceptable mismatches were defined with the single antigen beads Luminex assay, each test being individually interpreted with aid of the HLAMatchmaker algorithm. Negative-crossmatch prediction was validated in 86 T cell crossmatches using complement dependent cytotoxicity with anti-human globulin. Results: The estimation of the chances of 40 HSP to find a donor through the program showed that about 70% of them would be offered an ABO compatible, zero HLA-DR mismatched, T and B cell crossmatch negative graft within a two-year period after joining the program. On the other hand, for about 30% of the patients, the chances to find a suitable donor would be minimal, even after three or five years. Conclusions: We estimated that around 70% of the HSP would clearly benefit from the algorithm proposed in this study. On the other hand, those patients for whom it would be highly improbable to find a compatible donor would be primary candidates for desensitization/antibody reduction protocols. Therefore, we concluded that the information regarding the transplantability of each HSP provided by the algorithm herein described is a powerful tool for a proper management of highly sensitized patients in regional, national and international organizations as to deceased donor kidneys distribution.

Downloads

Download data is not yet available.

Downloads

Published

2010-01-01

How to Cite

Campos, Érika F., Doxiadis, I. I. N., Temin, J., Plothow, A., Bellintani, E. C., Miyamoto, Y., Dantas, L. V., Medina-Pestana, J. O., Claas, F., & Gerbase-DeLima, M. (2010). Proposal for a program to enhance renal transplantation opportunity for highly sensitized patients. Brazilian Journal of Transplantation, 13(1), 1251–1255. https://doi.org/10.53855/bjt.v13i1.223

Issue

Section

Original Paper